FDA 510(k)

Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables

K-Number: K203556 · 2021-07-12

Decision Date2021-07-12

Product CodeDSA

Advisory CommitteeCV

DecisionSubstantially Equivalent

Device Summary

Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic, Inc.. It received FDA 510(k) clearance on 2021-07-12 under 510(k) number K203556. The device is classified under product code DSA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables?

Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables is a medical device that received FDA 510(k) clearance on 2021-07-12. The listed applicant is Medtronic, Inc.. The 510(k) number is K203556.

When did Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables receive FDA 510(k) clearance?

Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables received FDA 510(k) clearance on 2021-07-12, under 510(k) number K203556.

Who is the listed applicant for Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables?

The FDA 510(k) record lists Medtronic, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables?

The FDA product code for Medtronic Model 5492A, 5492V, 5492AL, 5492VL Patient Cables is DSA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Other records listing Medtronic, Inc. as applicant

K262913Protégé™ EverFlex™ Self-expanding Peripheral Stent System K262735LINQ II Insertable Cardiac Monitor (ICM) (LNQ22)K262005Affera Integrated Mapping System K261335VitalFlow Set with Balance™ Biosurface K261866Concerto Versa™ Detachable Coil K260195Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae

View all 182 devices →

Related Devices (Code: DSA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.